Benjamin N. Greener

506 total citations · 1 hit paper
8 papers, 321 citations indexed

About

Benjamin N. Greener is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Benjamin N. Greener has authored 8 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Benjamin N. Greener's work include HIV Research and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and HIV/AIDS drug development and treatment (3 papers). Benjamin N. Greener is often cited by papers focused on HIV Research and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and HIV/AIDS drug development and treatment (3 papers). Benjamin N. Greener collaborates with scholars based in United States and Japan. Benjamin N. Greener's co-authors include Jessica Adams, Angela D. M. Kashuba, Matthew D. Weitzman, Iñigo Narvaiza, David J. Pintel, Eric C. Logue, Nathaniel R. Landau, Yoshiyuki Hakata, James Mond and Julie B. Dumond and has published in prestigious journals such as The Lancet Infectious Diseases, PLoS Pathogens and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Benjamin N. Greener

7 papers receiving 309 citations

Hit Papers

Immunogenicity and safety of a booster dose of a self-amp... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
    2023 63 citations Yoshiaki Oda, Yuji Kumagai et al. The Lancet Infectious Diseases profile →

Peers

Benjamin N. Greener
Mayumi Imahashi Japan
Jori Symons Australia
Stefano Berrè France
Katherine A. Lau Australia
Pantxika Bellecave France
Hongshuo Song United States
Hugh C. Welles United States
Daniëlle van Manen Netherlands
Sam X. Li United States
Roberto Fernandez-Larsson United States
Mayumi Imahashi Japan
Benjamin N. Greener
Citations per year, relative to Benjamin N. Greener Benjamin N. Greener (= 1×) peers Mayumi Imahashi

Countries citing papers authored by Benjamin N. Greener

Since Specialization
Citations

This map shows the geographic impact of Benjamin N. Greener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin N. Greener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin N. Greener more than expected).

Fields of papers citing papers by Benjamin N. Greener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin N. Greener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin N. Greener. The network helps show where Benjamin N. Greener may publish in the future.

Co-authorship network of co-authors of Benjamin N. Greener

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin N. Greener. A scholar is included among the top collaborators of Benjamin N. Greener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin N. Greener. Benjamin N. Greener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Oda, Yoshiaki, et al.. (2023). Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. The Lancet Infectious Diseases. 24(4). 351–360. 63 indexed citations breakdown →
2.
Greener, Benjamin N., et al.. (2022). ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections. Immunological Medicine. 46(1). 58–60.
3.
Wasserman, Richard L., et al.. (2019). Manufacturing Process Optimization of ADMA Biologics’ Intravenous Immunoglobulin Products, BIVIGAM ® and ASCENIV™. Immunotherapy. 11(16). 1423–1433. 8 indexed citations
4.
Wasserman, Richard L., Benjamin N. Greener, & James Mond. (2017). RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations. Expert Review of Clinical Immunology. 13(12). 1107–1119. 21 indexed citations
5.
Greener, Benjamin N., Kristine B. Patterson, Heather M. A. Prince, et al.. (2013). Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV-Negative Men After Single and Multiple Dosing. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(1). 39–44. 47 indexed citations
6.
Adams, Jessica, Kristine B. Patterson, Heather M. A. Prince, et al.. (2013). Single and Multiple Dose Pharmacokinetics of Dolutegravir in the Genital Tract of HIV-Negative Women. Antiviral Therapy. 18(8). 1005–1013. 28 indexed citations
7.
Adams, Jessica, Benjamin N. Greener, & Angela D. M. Kashuba. (2012). Pharmacology of HIV integrase inhibitors. Current Opinion in HIV and AIDS. 7(5). 390–400. 39 indexed citations
8.
Narvaiza, Iñigo, Benjamin N. Greener, Yoshiyuki Hakata, et al.. (2009). Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase. PLoS Pathogens. 5(5). e1000439–e1000439. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayumi Imahashi Breakdown of academic impact, for papers by Jori Symons Breakdown of academic impact, for papers by Stefano Berrè Breakdown of academic impact, for papers by Katherine A. Lau Breakdown of academic impact, for papers by Pantxika Bellecave Breakdown of academic impact, for papers by Hongshuo Song Breakdown of academic impact, for papers by Hugh C. Welles Breakdown of academic impact, for papers by Daniëlle van Manen Breakdown of academic impact, for papers by Sam X. Li Breakdown of academic impact, for papers by Roberto Fernandez-Larsson
Rankless by CCL
2026